Jamieson is delighted to announce that it has advised Chris Wootton and the management team of Chemigraphic on the acquisition of the investment made by NVM Private Equity (NWM). As part of the investment management will invest alongside NVM and become significant minority shareholders in the business.
Chemigraphic is the leading provider of Electronic Manufacturing Services (EMS) to the fast-growth medical technology, defence and power systems sectors. The investment will help to accelerate Chemigraphic’s international growth and drive continued development of its technology and expertise, particularly in the fast-growing med-tech sector. Chemigraphic CEO Chris Wootton, who joined the business in April 2017, was a former client of Jamieson and has a strong track record of creating value for institutional shareholders.